Entry
Name
Clematis root (JP18); Irei-sen (TN)
Component
Anemonin [CPD:
C16913 ], Protoanemonin [CPD:
C07090 ], Clematichinenoside A [CPD:
C17804 ], Clematichinenoside B [CPD:
C17805 ], Clematichinenoside C [CPD:
C17806 ], Huzhongoside B [CPD:
C17807 ], Clemaphenol A [CPD:
C17808 ], Hederagenin, Oleanolic acid [CPD:
C17148 ]
Source
Clematis chinensis, Clematis manshurica, Clematis hxapetala [TAX:
174171 ], Clematis [TAX:
3452 ]
Remark
Therapeutic category: 5100
Efficacy
Antibacterial, Hypoglycemic
Comment
Ranunculaceae (buttercup family) Clematis root
Major component: Anemonin [CPD:
C16913 ]
Brite
Therapeutic category of drugs in Japan [BR:br08301 ]
5 Crude drugs and Chinese medicine formulations
51 Crude drugs
510 Crude drugs
5100 Crude drugs
D06694 Clematis root (JP18)
Risk category of Japanese OTC drugs [BR:br08312 ]
Second-class OTC drugs
Crude drugs
Clematis root
D06694 Clematis root (JP18)
Third-class OTC drugs
Crude drugs
Clematis root
D06694 Clematis root (JP18)
Traditional Chinese Medicine in Japan [BR:br08304 ]
Crude drugs
Drugs for dampness
Antirheumatic drugs
D06694 Clematis root; Irei-sen
Drugs for external use
Drugs for external use
D06694 Clematis root; Irei-sen
Crude drugs [BR:br08305 ]
Dicot plants: others
Ranunculaceae (buttercup family)
D06694 Clematis root
Drugs listed in the Japanese Pharmacopoeia [BR:br08311 ]
Crude drugs
D06694 Clematis root
BRITE hierarchy
Other DBs
LinkDB
All DBs